U.S. RESEARCH ROUNDUP- BioLife Solutions, Gossamer Bio, Intuit
U.S. RESEARCH ROUNDUP- BioLife Solutions, Gossamer Bio, Intuit July 28 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including BioLife Solutions, Gossamer Bio and Intuit, on Tuesday.
HIGHLIGHTS
* BioLife Solutions Inc BLFS.O: Stephens cuts to equal weight from overweight |
* Gossamer Bio Inc GOSS.O: Leerink Partners raises to outperform from market perform |
* Intuit Inc INTU.O: TD Cowen cuts to hold from buy |
* International Paper Co IP.N: JP Morgan raises to overweight from neutral |
* MapLight Therapeutics Inc MPLT.O: Canaccord Genuity cuts target price to $24 from $43 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* 1St Source Corp SRCE.O: Piper Sandler raises target price to $100 from $88 |
* Abbott ABT.N: UBS cuts target price to $125 from $135 |
* Agilysys Inc AGYS.O: Needham raises target price to $130 from $120 |
* Agilysys Inc AGYS.O: Piper Sandler raises target price to $120 from $110 |
* Agilysys Inc AGYS.O: Oppenheimer raises target price to $118 from $100 |
* Albertsons Companies Inc ACI.N: UBS cuts to neutral from buy; cuts PT to $12 from $20 |
* Alpha Metallurgical Resources Inc AMR.N: B. Riley cuts target price to $189 from $194 |
* Alphatec Holdings Inc ATEC.O: UBS initiates coverage with buy rating; target price $15 |
* Alpine Income Property Trust PINE.N: Raymond James cuts to outperform from strong buy |
* Amazon AMZN.O: BMO raises target price to $360 from $355 |
* Amazon AMZN.O: Mizuho cuts target price to $320 from $325 |
* Amazon AMZN.O: UBS cuts target price to $305 from $333 |
* Ameris Bancorp ABCB.N: Truist Securities cuts target price to $90 from $92 |
* Amkor Technology Inc AMKR.O: B. Riley cuts target price to $65 from $75 |
* Amkor Technology Inc AMKR.O: Morgan Stanley raises target price to $70.00 from $69.00 |
* Arko Petroleum Corp APC.O: Mizuho raises target price to $22 from $20 |
* Atricure Inc ATRC.O: UBS cuts target price to $50 from $55 |
* AXT Inc AXTI.O: B. Riley cuts target price to $52 from $73 |
* Badger Meter Inc BMI.N: Barclays raises target price to $112 from $109 |
* Baker Hughes Co BKR.O: Piper Sandler raises target price to $73 from $71 |
* Baker Hughes Co BKR.O: Stifel raises target price to $75 from $74 |
* Baker Hughes Co BKR.O: Susquehanna raises target price to $72 from $70 |
* Baker Hughes Co BKR.O: TD Cowen raises target price to $78 from $77 |
* Baker Hughes Co BKR.O: UBS cuts target price to $71 from $73 |
* Bank of Hawaii Corporation BOH.N: Barclays cuts target price to $85 from $88 |
* Bankwell Financial Group Inc BWFG.O: KBW raises target price to $72 from $62 |
* Bath & Body Works Inc BBWI.N: Jefferies raises target price to $23 from $22 |
* Baxter BAX.N: Stifel raises target price to $24 from $19 |
* Baxter BAX.N: UBS assumes coverage with neutral rating; target price $25 vs $19 |
* Bd BDX.N: UBS initiates coverage with buy rating; price target $190 |
* Bellring Brands Inc BRBR.N: JP Morgan raises target price to $17 from $13 |
* Benitec Biopharma BNTC.O: Wedbush initiates coverage with outperform rating; PT $16 |
* Berkshire Hathaway BRKa.N: UBS raises target price to $877,848 from $854,596 |
* Berkshire Hathaway BRKb.N: UBS raises target price to $585 from $570 |
* Beta Bionics Inc BBNX.O: UBS cuts target price to $22 from $24 |
* Biolife Solutions Inc BLFS.O: Stephens cuts to equal weight from overweight |
* Biolife Solutions Inc BLFS.O: Stephens cuts target price to $31 from $32 |
* Blue Owl Capital Inc OWL.N: JP Morgan raises target price to $10.50 from $10 |
* Boston Scientific Corp BSX.N: UBS cuts target price to $74 from $95 |
* Brinker International Inc EAT.N: Citigroup raises target price to $227 from $189 |
* Brixmor Property Group Inc BRX.N: Stifel raises target price to $34 from $31 |
* Builders Firstsource Inc BLDR.N: BMO cuts target price to $85 from $93 |
* Byline Bancorp Inc BY.N: Piper Sandler raises target price to $46 from $40 |
* Cadence Design CDNS.O: Deutsche Bank raises target price to $400 from $375 |
* Cadence Design Systems Inc CDNS.O: BofA Global Research raises PT to $420 from $400 |
* Cadence Design Systems Inc CDNS.O: Citigroup raises target price to $420 from $400 |
* Cadence Design Systems Inc CDNS.O: Piper Sandler raises target price to $349 from $325 |
* Cadence Design Systems Inc CDNS.O: Rosenblatt Securities raises target price to $420 from $410 |
* Cadence Design Systems Inc. CDNS.O: Oppenheimer raises target price to $300 from $275 |
* Cantor Equity Partners Ii Inc SECZ.N: Citigroup initiates coverage with buy rating; target price $10 |
* Capricor Therapeutics Inc CAPR.O: B. Riley cuts to neutral from buy; cuts PT to $10 from $63 |
* Cava Group Inc CAVA.N: Citigroup cuts target price to $79 from $92 |
* CBRE Group, Inc. CBRE.N: Barclays raises target price to $180 from $178 |
* Central Pacific Financial Corp CPF.N: Piper Sandler raises target price to $43 from $41 |
* CF Industries Holdings Inc CF.N: Exane BNP Paribas raises target price to $130 from $120 |
* Ch Robinson Worldwide Inc CHRW.O: Baird cuts target price to $200 from $230 |
* Ch Robinson Worldwide Inc CHRW.O: TD Cowen cuts target price to $155 from $200 |
* Chemung Financial Corp CHMG.O: KBW raises target price to $81 from $77 |
* Chevron Corp CVX.N: BofA Global Research raises price objective to $227 from $210 |
* Cinemark Holdings Inc CNK.N: Baird raises target price to $40 from $37 |
* Cipher Digital Inc CIFR.O: KBW raises target price to $32 from $27 |
* Cleanspark Inc CLSK.O: KBW raises target price to $25 from $16 |
* Clear Secure Inc YOU.N: D.A. Davidson cuts target price to $55 from $60 |
* Clorox CLX.N: Jefferies cuts to hold from buy; cuts target price to $98 from $125 |
* Commvault Systems Inc CVLT.O: Piper Sandler cuts to neutral from overweight |
* Constellation Energy CEG.O: Barclays cuts target price to $324 from $358 |
* Constellation Energy Corp CEG.O: Raymond James cuts target price to $346 from $374 |
* Constellation Energy Corp CEG.O: UBS cuts target price to $380 from $388 |
* Cooper Companies Inc COO.O: UBS initiates coverage with neutral rating; target price $75 |
* Corpay Inc CPAY.N: Morgan Stanley raises target price to $415.00 from $400.00 |
* Crinetics Pharmaceuticals Inc CRNX.O: UBS cuts to neutral from buy; cuts target price to $85 from $55 |
* Crown Castle Inc CCI.N: Truist Securities cuts target price to $87 from $95 |
* CVB Financial Corp CVBF.O: Stephens raises target price to $25 from $23 |
* Datadog Inc DDOG.O: BTIG raises target price to $289 from $255 |
* Datadog Inc DDOG.O: Citigroup raises target price to $300 from $270 |
* Datadog, Inc. DDOG.O: Morgan Stanley raises target price to $300.00 from $225.00 |
* Dexcom Inc DXCM.O: UBS resumes coverage with buy rating; target price $96 vs $95 |
* Duolingo Inc DUOL.O: Scotiabank raises target price to $130 from $100 |
* Eastgroup Properties Inc EGP.N: Truist Securities raises target price to $230 from $215 |
* Ecolab Inc ECL.N: Mizuho raises target price to $327 from $325 |
* Edwards Lifesciences Corp EW.N: UBS assumes coverage with buy vs neutral rating; target price $110 vs $90 |
* Elf Beauty Inc ELF.N: Jefferies raises target price to $100 from $72 |
* Enovis Corp ENOV.N: UBS assumes coverage with buy rating; price target $51 vs $50 |
* Ensign Group, Inc ENSG.O: RBC raises target price to $228 from $222 |
* Esquire Financial Holdings Inc ESQ.O: Raymond James raises target price to $140 from $130 |
* Estée Lauder EL.N: Jefferies raises target price to $88 from $80 |
* Evolent Health Inc EVH.N: TD Cowen cuts target price to $5 from $8 |
* Exxon Mobil XOM.N: BofA Global Research cuts to neutral from buy; raises price objective to $158 from $154 |
* F5 Inc FFIV.O: JP Morgan raises target price to $515 from $500 |
* F5 Inc FFIV.O: Morgan Stanley raises target price to $415.00 from $380.00 |
* F5 Inc FFIV.O: Piper Sandler raises target price to $461 from $423 |
* F5 Inc FFIV.O: RBC raises target price to $508 from $490 |
* F5, Inc. FFIV.O: Barclays raises target price to $397 from $386 |
* Faeth Therapeutics, Inc FTH.O: Oppenheimer initiates coverage with outperform rating; price target $60 |
* Fermi Inc FRMI.O: Mizuho cuts target price to $11 from $27 |
* Firefly Aerospace Inc. FLY.O: Wells Fargo initiates coverage with equal weight rating and target price $25 |
* First Citizens Bancshares FCNCA.O: Truist Securities raises target price to $2323 from $2150 |
* First Industrial Realty Trust Inc FR.N: Truist Securities raises target price to $73 from $67 |
* First Mid Bancshares Inc FMBH.O: Piper Sandler raises target price to $62.50 from $55 |
* First Tracks Biotherapeutics Inc TRAX.O: Wedbush raises target price to $60 from $30 |
* First Tracks Biotherapeutics Inc. TRAX.O: Wells Fargo raises target price to $55 from $30 |
* Flutter Entertainment Plc FLUT.N: BTIG cuts target price to $120 from $126 |
* FMC AG FMS.N: Exane BNP Paribas cuts to underperform from neutral |
* Forte Biosciences Inc FBRX.O: Barclays cuts to equal-weight from overweight |
* Forte Biosciences Inc FBRX.O: Barclays raises target price to $77 from $74 |
* Fortune Brands Innovations Inc FBIN.N: BMO raises target price to $53 from $50 |
* Freshpet Inc FRPT.O: JP Morgan raises target price to $72 from $68 |
* Getty Realty Corp GTY.N: JP Morgan raises target price to $37 from $33 |
* Glaukos Corp GKOS.N: UBS cuts to neutral from buy |
* Globus Medical Inc GMED.N: UBS initiates coverage with neutral rating; target price $82 |
* Goosehead Insurance Inc GSHD.O: JP Morgan raises target price to $68 from $60 |
* Gossamer Bio Inc GOSS.O: Leerink Partners raises to outperform from market perform |
* H & R Block Inc HRB.N: Stephens initiates coverage with equal weight rating; price target $47 |
* Happen Inc HAPN.O: Piper Sandler raises target price to $25 from $23 |
* Harley-Davidson Inc HOG.N: Morgan Stanley raises target price to $17.00 from $15.00 |
* Hartford Insurance Group Inc HIG.N: JP Morgan raises target price to $157 from $152 |
* Hbt Financial, Inc HBT.O: KBW raises target price to $38 from $34 |
* Hbt Financial, Inc HBT.O: Raymond James raises target price to $38 from $31 |
* HCA Healthcare Inc HCA.N: Bernstein raises target price to $426 from $413 |
* HCA Healthcare Inc HCA.N: Leerink Partners cuts target price to $492 from $500 |
* HCA Healthcare Inc HCA.N: Mizuho cuts target price to $475 from $525 |
* HCA Healthcare Inc HCA.N: Morgan Stanley cuts target price to $380 from $425 |
* Henry Schein Inc HSIC.O: UBS raises target price to $89 from $85 |
* Heritage Financial Corp HFWA.O: Stephens raises target price to $32 from $30 |
* Hertz Global Holdings Inc. HTZ.O: Barclays cuts target price to $1 from $3 |
* Hilltop Holdings Inc HTH.N: Piper Sandler raises target price to $42 from $40 |
* Honeywell Technologies HON.O: BofA Global Research raises price objective to $265.00 from $205.00 |
* Honeywell Technologies HON.O: BofA Global Research raises to neutral from underperform rating |
* Huntington Bancshares Inc HBAN.O: Truist Securities raises target price to $20 from $19 |
* Hut 8 Corp HUT.O: KBW raises target price to $157 from $138 |
* Inspire Medical Systems Inc INSP.N: UBS assumes coverage with sell vs neutral rating; target price $39 vs $67 |
* Insulet Corp PODD.O: UBS resumes coverage with neutral vs buy rating; target price $174 vs $400 |
* Integra Lifesciences Holdings Corp IART.O: UBS initiates coverage with neutral rating; target price $19 |
* International Paper Co IP.N: JP Morgan raises to overweight from neutral; raises target price to $61 from $51 |
* Interparfums Inc IPAR.O: Jefferies raises target price to $145 from $115 |
* Intuit Inc INTU.O: TD Cowen cuts to hold from buy; cuts target price to $304 from $504 |
* Intuitive Surgical Inc ISRG.O: UBS assumes coverage with buy vs neutral rating; target price $500 vs $550 |
* ITG Inc ITG.O: Morgan Stanley initiates coverage with overweight rating; price target $19 |
* Jfrog Ltd FROG.O: BTIG raises target price to $100 from $80 |
* Jones Lang LaSalle Inc. JLL.N: Barclays raises target price to $368 from $366 |
* Kinsale Capital Group Inc KNSL.N: BMO raises target price to $342 from $335 |
* Kodiak Gas Services Inc KGS.N: Piper Sandler initiates coverage with overweight rating; price target $78 |
* Lamb Weston Holdings Inc LW.N: Bernstein raises target price to $57 from $42 |
* Lamb Weston Holdings Inc LW.N: Stephens raises target price to $55 from $46 |
* Lamb Weston Holdings Inc LW.N: TD Cowen raises target price to $52 from $40 |
* Lamb Weston Holdings, Inc. LW.N: Barclays raises target price to $56 from $50 |
* Landstar System Inc LSTR.O: TD Cowen cuts target price to $178 from $200 |
* Lantheus Holdings Inc LNTH.O: Leerink Partners raises target price to $113 from $103 |
* Las Vegas Sands Corp. LVS.N: Wells Fargo cuts target price to $48 from $53 |
* Laureate Education Inc LAUR.O: Morgan Stanley cuts to underweight from equal weight; cuts PT to $34.5 from $36.5 |
* Legend Biotech Corp LEGN.O: Raymond James cuts target price to $58 from $86 |
* Levi Strauss & Co. LEVI.N: Wells Fargo cuts to equal weight from overweight |
* Liberty Media FWONK.O: Bernstein raises target price to $119 from $115 |
* Live Nation Entertainment Inc. LYV.N: Oppenheimer raises target price to $200 from $190 |
* Lockheed Martin Corp LMT.N: TD Cowen raises target price to $600 from $560 |
* Magnolia Oil & Gas Corp MGY.N: Truist Securities raises to buy from hold; raises target price to $33 from $32 |
* Maplight Therapeutics Inc MPLT.O: BMO cuts target price to $20 from $46 |
* Maplight Therapeutics Inc MPLT.O: Canaccord Genuity cuts target price to $24 from $43 |
* Maplight Therapeutics Inc MPLT.O: Jefferies cuts target price to $25 from $34 |
* Maplight Therapeutics Inc MPLT.O: Morgan Stanley cuts to equal weight from overweight; cuts target price to $21 from $34 |
* Maplight Therapeutics, Inc. MPLT.O: H.C. Wainwright cuts target price to $26 from $45 |
* Matador Resources Co MTDR.N: Stephens raises target price to $93 from $92 |
* Metropolitan Bank Holding Corp MCB.N: UBS cuts target price to $100 from $110 |
* Midland States Bancorp Inc MSBI.O: Piper Sandler raises target price to $35 from $32 |
* Molina Healthcare, Inc. MOH.N: Wells Fargo cuts target price to $220 from $235 |
* Mosaic Co MOS.N: Exane BNP Paribas raises target price to $32 |
* Navitas Semiconductor Corp NVTS.O: Jefferies cuts target price to $13 from $15 |
* Navitas Semiconductor Corp NVTS.O: Morgan Stanley cuts target price to $12.60 from $13.70 |
* Newmont NEM.N: CIBC cuts target price to $168 from $175 |
* Newmont Mining Corp. NEM.N: Barclays cuts target price to $124 from $125 |
* Nextera Energy NEE.N: HSBC raises target price to $114 from $106 |
* NRG Energy Inc NRG.N: Barclays raises target price to $204 from $200 |
* NRG Energy Inc NRG.N: BMO cuts target price to $212 from $213 |
* NRG Energy Inc NRG.N: Raymond James cuts target price to $182 from $194 |
* NRG Energy Inc NRG.N: UBS cuts target price to $216 from $221 |
* Nucor Corp NUE.N: UBS raises target price to $256 from $224 |
* Nurix Therapeutics Inc NRIX.O: Morgan Stanley raises target price to $38 from $36 |
* Nutrien Ltd NTR.N: Exane BNP Paribas raises to outperform from neutral |
* Old National Bancorp ONB.O: Truist Securities raises target price to $29 from $28 |
* Otis Worldwide Corp OTIS.N: RBC cuts target price to $90 from $98 |
* Ovintiv Inc OVV.N: UBS raises target price to $74 from $71 |
* Packaging Corp of America PKG.N: JP Morgan raises target price to $312 from $271 |
* PayPal PYPL.O: Susquehanna raises target price to $67 from $63 |
* Phibro Animal Health Corp PAHC.O: BofA Global Research cuts price objective to $35 from $38 |
* Pinnacle Financial Partners Inc PNFP.N: Truist Securities raises target price to $118 from $115 |
* Principal Financial Group Inc PFG.O: BofA Global Research raises price objective to $104 from $94 |
* Procept Biorobotics Corp PRCT.O: UBS assumes coverage with neutral vs buy rating; target price $20 vs $30 |
* Procore Technologies Inc PCOR.N: TD Cowen cuts target price to $60 from $70 |
* Progyny PGNY.O: Barclays cuts to equal-weight from overweight |
* Progyny PGNY.O: Barclays raises target price to $34 from $27 |
* Pulse Biosciences Inc. PLSE.O: Oppenheimer raises target price to $35 from $30 |
* Q32 Bio Inc. QTTB.O: H.C. Wainwright raises target price to $36 from $13 |
* Quest Diagnostics Inc DGX.N: JP Morgan raises target price to $250 from $220 |
* Qxo Inc QXO.N: Wells Fargo resumes coverage with overweight rating; price target $18 |
* Rapport Therapeutics Inc RAPP.O: William Blair initiates coverage with outperform rating |
* Riot Platforms Inc RIOT.O: KBW cuts target price to $35 from $37 |
* Rxo Inc RXO.N: TD Cowen cuts to sell from hold; cuts target price to $19 from $24 |
* Rxsight Inc RXST.O: UBS cuts target price to $5.5 from $9 |
* Sanmina Corp SANM.O: JP Morgan cuts target price to $260 from $275 |
* Sanmina Corp SANM.O: Susquehanna raises target price to $210 from $185 |
* Selective Insurance Group Inc SIGI.O: BMO cuts to market perform from outperform |
* Shore Bancshares Inc SHBI.O: KBW raises target price to $25 from $22 |
* Shoulder Innovations Inc SI.N: UBS initiates coverage with buy rating; target price $27 |
* Si-Bone Inc SIBN.O: UBS initiates coverage with buy rating; target price $24 |
* Sight Sciences Inc SGHT.O: UBS cuts target price to $7 from $11 |
* Simpson Manufacturing Co Inc SSD.N: Stephens raises target price to $215 from $210 |
* Solventum Corp SOLV.N: UBS assumes coverage with buy vs neutral rating; target price $95 vs $78 |
* Southstate Bank Corp SSB.N: TD Cowen raises target price to $120 from $114 |
* Southstate Bank Corp SSB.N: Truist Securities raises target price to $118 from $108 |
* Staar Surgical Co STAA.O: UBS initiates coverage with sell rating; target price $20 |
* Stem STEM.N: Barclays cuts target price to $8 from $18 |
* Stryker Corp SYK.N: UBS assumes coverage with buy vs neutral rating; target price $400 vs $380 |
* Talen Energy Corp TLN.O: Barclays cuts target price to $408 from $411 |
* Talen Energy Corp TLN.O: Raymond James raises target price to $463 from $456 |
* Tandem Diabetes Care Inc TNDM.O: UBS cuts target price to $18 from $22 |
* Teleflex Inc TFX.N: UBS initiates coverage with neutral rating; target price $145 |
* Tenax Therapeutics Inc TENX.O: Canaccord Genuity initiates coverage with buy rating |
* Tenax Therapeutics Inc TENX.O: Canaccord Genuity initiates coverage with PT $35 |
* Tenet Healthcare Corp THC.N: Jefferies raises target price to $285 from $250 |
* Tenet Healthcare Corp THC.N: Leerink Partners raises target price to $309 from $218 |
* Tenet Healthcare Corp THC.N: Morgan Stanley raises target price to $274 from $254 |
* Tenet Healthcare Corp THC.N: Raymond James raises target price to $275 from $228 |
* Tenet Healthcare Corp THC.N: Truist Securities raises target price to $290 from $270 |
* Terawulf Inc WULF.O: KBW cuts target price to $30 from $33 |
* Tesla Inc TSLA.O: RBC cuts target price to $480 from $500 |
* Tko Group TKO.N: Bernstein cuts target price to $235 from $240 |
* Trex Company Inc TREX.N: BMO raises target price to $56 from $54 |
* Trex Company Inc TREX.N: Stephens raises target price to $50 from $45 |
* Twilio Inc TWLO.N: BTIG raises target price to $245 from $215 |
* Uber UBER.N: BofA Global Research cuts price objective to $103 from $104 |
* Universal Health Services Inc. UHS.N: Barclays cuts target price to $168 from $179 |
* Valvoline Inc VVV.N: Stephens raises target price to $48 from $44 |
* Victoria'S Secret & Co VSXY.N: JP Morgan raises target price to $110 from $88 |
* Virtu Financial Inc VIRT.N: JP Morgan raises target price to $59 from $51 |
* Vistra Corp VST.N: Raymond James cuts target price to $186 from $202 |
* Vistra Corp VST.N: UBS cuts target price to $227 from $233 |
* Vita Coco Company Inc COCO.O: Morgan Stanley raises target price to $68 from $65 |
* Waste Connections, Inc WCN.N: Barclays raises target price to $187 from $180 |
* Wayfair Inc W.N: JP Morgan raises target price to $108 from $105 |
* Wynn Resorts Ltd WYNN.O: Mizuho cuts target price to $125 from $133 |
* Zimmer Biomet Holdings ZBH.N: UBS assumes coverage with buy vs sell rating; PT $115 vs $89 |
* Zoetis Inc ZTS.N: BofA Global Research cuts price objective to $90 from $108 |
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Recent news on Agilysys
See all newsU.S. RESEARCH ROUNDUP- BioLife Solutions, Gossamer Bio, Intuit
Agilysys Inc reports results for the quarter ended June 30 - Earnings Summary
Agilysys lifts FY revenue, subscription growth outlook after Q1 results beat
Brief: Agilysys Q1 Adjusted EPS USD 0.49 Vs. IBES Estimate USD 0.4
Agilysys Q4 revenue rises on subscription growth